Anabolic Androgenic Steroids

Andrew B. Parkinson · Nick A. Evans

430 citations0/0 files storedMedicine & Science in Sports & Exercise

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Doping in Sports Hormonal and reproductive studies Pharmacological Effects and Assays

Abstract

PURPOSE: The use of anabolic androgenic steroids (AAS) to increase muscle size and strength is widespread. Information regarding self-administered AAS used nonmedically to enhance athletic performance or improve physical appearance is sparse and poorly documented. The purpose of this study is to identify current trends in the drug-taking habits of AAS users. METHODS: An anonymous self-administered questionnaire was posted on the message boards of Internet Web sites popular among AAS users. RESULTS: Of the 500 AAS users who participated in the survey, 78.4% (392/500) were noncompetitive bodybuilders and nonathletes; 59.6% (298/500) of the respondents reported using at least 1000 mg of testosterone or its equivalent per week. The majority (99.2%) of AAS users (496/500) self-administer injectable AAS formulations, and up to 13% (65/500) report unsafe injection practices such as reusing needles, sharing needles, and sharing multidose vials. In addition to using AAS, 25% of users admitted to the adjuvant use of growth hormone and insulin for anabolic effect, and 99.2% (496/500) of users reported subjective side effects from AAS use. CONCLUSIONS: This survey reveals several trends in the nonmedical use of AAS. Nearly four out of five AAS users are nonathletes who take these drugs for cosmetic reasons. AAS users in this sample are taking larger doses than previously recorded, with more than half of the respondents using a weekly AAS dose in excess of 1000 mg. The majority of steroid users self-administer AAS by intramuscular injection, and approximately 1 in 10 users report hazardous injection techniques. Polypharmacy is practiced by more than 95% of AAS users, with one in four users taking growth hormone and insulin. Nearly 100% of AAS users reported subjective side effects.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 430 citations exist upstream.

References

2002Using the Internet for Surveys and Health Research 1997How to read a paper: Papers that go beyond numbers (qualitative research)1994Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use 1999Using the Internet for psychological research: Personality testing on the World Wide Web

Cited by

2013The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: Current best estimates 2009Illicit anabolic–androgenic steroid use 2007A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States 2017History and epidemiology of anabolic androgens in athletes and non-athletes 2008Psychological drivers in doping: The life-cycle model of performance enhancement 2011The Anabolic 500 Survey: Characteristics of Male Users versus Nonusers of Anabolic‐Androgenic Steroids for Strength Training 2011Anabolic androgenic steroids abuse and cardiac death in athletes: Morphological and toxicological findings in four fatal cases 2010His biceps become him: A test of objectification theory's application to drive for muscularity and propensity for steroid use in college men.

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.